PAC-MAN / Stanford University, DNARx 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
  • ||||||||||  PAC-MAN / Stanford University, DNARx
    Journal:  A comprehensive analysis and resource to use CRISPR-Cas13 for broad-spectrum targeting of RNA viruses. (Pubmed Central) -  Mar 30, 2021   
    We also build an online resource (crispr-pacman.stanford.edu) to support community use of CRISPR-Cas13 for broad-spectrum RNA virus targeting. Our work provides a new bioinformatic resource for using CRISPR-Cas13 to target diverse RNA viruses in order to facilitate development of CRISPR-based antivirals.